Pharmaffiliates
Pharmaffiliates, officially known as Pharmaffiliates Analytics and Solutions Ltd., is a prominent player in the pharmaceutical and biotechnology industry, headquartered in India. Established in 2008, the company has rapidly expanded its operational footprint across major regions, including North America, Europe, and Asia. Specialising in regulatory affairs, clinical research, and analytical services, Pharmaffiliates distinguishes itself through its commitment to quality and innovation. The company offers a comprehensive suite of services, including drug development support and market authorisation assistance, tailored to meet the diverse needs of its clients. With a strong market position, Pharmaffiliates has achieved notable milestones, including successful collaborations with leading pharmaceutical companies. Its dedication to excellence and customer satisfaction has solidified its reputation as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Pharmaffiliates's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaffiliates's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaffiliates's reported carbon emissions
Pharmaffiliates, headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Pharmaffiliates has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pharmaffiliates to establish clear climate commitments and reduction initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaffiliates is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
